Renovaro Biosciences (RENB) - 2021 Q4 - Annual Report

FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the fiscal year ended June 30, 2021 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission file number 000-54478 ENOCHIAN BIOSCIENCES INC. (Name of registrant in its charter) | Delaware | | 45-2559340 | | --- | --- | --- | | (State or other jurisdiction of | | (I.R.S. Empl ...